Copyright
©The Author(s) 2025.
World J Hepatol. Apr 27, 2025; 17(4): 104890
Published online Apr 27, 2025. doi: 10.4254/wjh.v17.i4.104890
Published online Apr 27, 2025. doi: 10.4254/wjh.v17.i4.104890
Table 1 Quality assessment for the Cochrane collaboration’s tool for assessing randomized controlled trials
Ref. | Country | Selection bias | Performance bias | Measuring bias | Attrition bias | Publication bias | Other bias |
Riggio et al[35], 2005 | Italy | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
Bass et al[36], 2010 | America | Low risk | Low risk | Medium risk | Low risk | Low risk | Low risk |
Bai et al[37], 2014 | China | Low risk | Low risk | Low risk | Medium risk | Low risk | Low risk |
Bureau et al[7], 2021 | France | Low risk | Low risk | Low risk | Medium risk | Low risk | Low risk |
- Citation: Xu XT, Jiang MJ, Fu YL, Xie F, Li JJ, Meng QH. Incidence and efficacy of strategies for preventing hepatic encephalopathy following transjugular intrahepatic portosystemic shunt: A meta-analysis. World J Hepatol 2025; 17(4): 104890
- URL: https://www.wjgnet.com/1948-5182/full/v17/i4/104890.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i4.104890